Home » GENERIC OMNICEF GETS FDA APPROVAL
GENERIC OMNICEF GETS FDA APPROVAL
The FDA has approved Lupin's Cefdinir, the generic version of Abbott's Omnicef, a treatment for bacterial infections. The company will market Cefdinir powder for oral suspension in 125 mg/5 mL strength.
In May, Lupin received approval for a generic version of Omnicef in a capsule formulation.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May